US Stock MarketDetailed Quotes
TMO Thermo Fisher Scientific
- 547.250
- -7.300-1.32%
Close Apr 17 16:00 ET
- 536.000
- -11.250-2.06%
Pre 08:16 ET
208.89BMarket Cap35.42P/E (TTM)
556.000High546.450Low1.61MVolume555.860Open554.550Pre Close883.79MTurnover0.42%Turnover Ratio35.42P/E (Static)381.71MShares603.42152wk High4.47P/B208.40BFloat Cap415.04352wk Low1.40Dividend TTM380.82MShs Float668.602Historical High0.26%Div YieldTTM1.72%Amplitude11.901Historical Low548.915Avg Price1Lot Size
Thermo Fisher Scientific Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jul 1, 2023 | (Q1)Apr 1, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Oct 1, 2022 | (Q2)Jul 2, 2022 | (Q1)Apr 2, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -8.17%8.41B | 6.77%3.72B | 24.63%2.41B | 0.79%1.54B | -66.89%729M | -1.70%9.15B | 41.92%3.49B | -26.91%1.94B | -31.39%1.53B | 2.2B |
| Net income from continuing operations | -14.44%5.96B | 2.03%1.61B | 13.15%1.7B | -18.35%1.36B | -41.80%1.29B | -9.94%6.96B | -5.12%1.57B | -21.28%1.5B | -8.80%1.67B | --2.22B |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | -96.61%26M | --0 | --0 | --0 | --26M |
| Depreciation and amortization | 0.74%3.41B | -1.06%839M | 1.79%853M | 2.27%855M | 0.00%859M | 30.44%3.38B | 24.16%848M | 33.44%838M | 26.67%836M | --859M |
| Deferred tax | -30.65%-1.3B | -403.01%-669M | -16.09%-303M | 30.53%-182M | 56.93%-146M | -53.79%-995M | 30.73%-133M | -76.35%-261M | 20.85%-262M | ---339M |
| Other non cash items | 16.36%562M | 202.50%121M | -26.97%111M | 156.90%149M | -22.32%181M | 209.62%483M | 211.11%40M | 823.81%152M | -59.72%58M | --233M |
| Change In working capital | 50.89%-495M | 62.97%1.77B | 97.55%-9M | 15.43%-718M | -75.20%-1.53B | 33.42%-1.01B | 456.25%1.08B | -254.85%-367M | -573.81%-849M | ---875M |
| -Change in receivables | 126.66%209M | ---- | ---- | ---- | ---- | -4,711.76%-784M | ---- | ---- | ---- | ---- |
| -Change in inventory | 172.48%598M | ---- | ---- | ---- | ---- | 22.54%-825M | ---- | ---- | ---- | ---- |
| -Change in payables and accrued expense | -177.16%-500M | ---- | ---- | ---- | ---- | 35.28%648M | ---- | ---- | ---- | ---- |
| -Change in other working capital | -1,606.38%-802M | ---- | ---- | ---- | ---- | 95.03%-47M | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -8.17%8.41B | 6.77%3.72B | 24.63%2.41B | 0.79%1.54B | -66.89%729M | -1.70%9.15B | 41.92%3.49B | -26.91%1.94B | -31.39%1.53B | --2.2B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -138.17%-5.14B | 28.38%-376M | -116.70%-1.18B | -5.73%-443M | -368.96%-3.14B | 90.16%-2.16B | 97.19%-525M | 11.53%-545M | 33.07%-419M | -670M |
| Net PPE purchase and sale | 37.27%-1.39B | 27.57%-394M | 51.01%-266M | 43.32%-280M | 29.15%-452M | 11.35%-2.22B | 33.66%-544M | -4.42%-543M | 8.52%-494M | ---638M |
| Net business purchase and sale | -9,284.62%-3.66B | --0 | -91,000.00%-909M | ---47M | -6,660.00%-2.7B | 99.80%-39M | --0 | 101.06%1M | --0 | ---40M |
| Net investment purchase and sale | 366.67%70M | ---- | ---- | ---- | ---- | 87.50%15M | ---- | ---- | ---- | ---- |
| Net other investing changes | -290.48%-160M | -1,400.00%-52M | -100.00%-6M | -254.67%-116M | 75.00%14M | 300.00%84M | 200.00%4M | -50.00%-3M | 1,975.00%75M | --8M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -138.17%-5.14B | 28.38%-376M | -116.70%-1.18B | -5.73%-443M | -368.96%-3.14B | 90.16%-2.16B | 97.19%-525M | 11.53%-545M | 33.07%-419M | ---670M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -28.90%-3.62B | -159.72%-1.43B | 1,328.48%1.86B | 23.57%-1.46B | 17.55%-2.59B | -142.70%-2.81B | -71.76%2.39B | -104.97%-151M | -2,406.58%-1.91B | -3.15B |
| Net issuance payments of debt | -123.70%-155M | -137.44%-1.31B | 197,300.00%1.97B | 27.40%-1.33B | 150.00%504M | -92.66%654M | -59.40%3.49B | -100.03%-1M | ---1.83B | ---1.01B |
| Net common stock issuance | 0.00%-3B | --0 | --0 | --0 | -50.00%-3B | -50.00%-3B | ---1B | --0 | --0 | ---2B |
| Cash dividends paid | -14.95%-523M | -16.24%-136M | -14.41%-135M | -15.38%-135M | -13.59%-117M | -15.19%-455M | -13.59%-117M | -15.69%-118M | -13.59%-117M | ---103M |
| Net other financing activities | 722.22%56M | -30.00%14M | 156.25%18M | -89.19%4M | 158.82%20M | -113.85%-9M | -74.68%20M | -255.56%-32M | 248.00%37M | ---34M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -28.90%-3.62B | -159.72%-1.43B | 1,328.48%1.86B | 23.57%-1.46B | 17.55%-2.59B | -142.70%-2.81B | -71.76%2.39B | -104.97%-151M | -2,406.58%-1.91B | ---3.15B |
| Net cash flow | ||||||||||
| Beginning cash position | 90.09%8.54B | 110.22%6.17B | 65.51%3.15B | 25.94%3.5B | 90.09%8.54B | -56.55%4.49B | -75.65%2.93B | -72.92%1.91B | -50.40%2.78B | --4.49B |
| Current changes in cash | -108.55%-358M | -64.15%1.92B | 148.83%3.09B | 54.90%-359M | -210.35%-5.01B | 169.30%4.19B | 168.91%5.35B | -75.54%1.24B | -152.20%-796M | ---1.61B |
| Effect of exchange rate changes | 41.01%-82M | -96.00%10M | 65.57%-73M | 115.38%12M | 68.69%-31M | -171.65%-139M | 18.48%250M | -247.54%-212M | 16.13%-78M | ---99M |
| End cash Position | -5.15%8.1B | -5.15%8.1B | 110.22%6.17B | 65.51%3.15B | 25.94%3.5B | 90.09%8.54B | 90.09%8.54B | -75.65%2.93B | -72.92%1.91B | --2.78B |
| Free cash flow | 0.23%6.93B | 12.97%3.32B | 49.78%2.08B | 22.90%1.26B | -82.65%271M | 1.80%6.91B | 80.63%2.94B | -34.62%1.39B | -39.42%1.02B | --1.56B |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg